It's important to note that none of these improve outcomes, and niacin in particular worsens outcomes and insulin resistance, see the niacin article
14,15 Because of the results of these landmark clinical trials, evidence-based treatment guidelines now recommend the GLP-1/GIP agonists as an important second-line treatment for uncomplicated type 2 diabetics who fail to meet hemoglobin A1c targets on popular first-line agents such as metformin
Blissful Wellness had the best combination of expertise, comprehensive support, and fair pricing. Common Cost-Related Questions Can I use my insurance? Our programs are self-pay, but if your insurance covers brand-name Wegovy or Zepbound for weight loss, we can coordinate care and help with prior authorization
GLP-1 receptor agonists mimic a hormone your body already produces called glucagon-like peptide-1
The 9 mg dose reached 26.4%